| David George Rorison, MD | |
|
8105 Ritchie Hwy, Pasadena, MD 21122-3905 | |
| (443) 573-0564 | |
| Not Available |
| Full Name | David George Rorison |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 43 Years |
| Location | 8105 Ritchie Hwy, Pasadena, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083650253 | NPI | - | NPPES |
| 351011500 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | D0028260 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Patient First Maryland Medical Group Pllc | 4385538735 | 221 |
| Patient First Maryland Medical Group Pllc | 4385538735 | 221 |
News Archive
ULURU Inc. announced today that it has been issued U.S. Patent 7,910,135 – Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses.
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.
SARS-CoV-2-associated acute kidney injury is not uncommon. Many hospitalized COVID-19 patients - as many as 80% of critically ill COVID-19 patients, according to a current study - develop acute kidney injury, but without requiring dialysis in most cases. Proteinuria and hematuria are present in about half the cases.
› Verified 9 days ago
| Entity Name | University Of Maryland Emergency Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144271743 PECOS PAC ID: 1951294941 Enrollment ID: O20040204000360 |
News Archive
ULURU Inc. announced today that it has been issued U.S. Patent 7,910,135 – Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses.
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.
SARS-CoV-2-associated acute kidney injury is not uncommon. Many hospitalized COVID-19 patients - as many as 80% of critically ill COVID-19 patients, according to a current study - develop acute kidney injury, but without requiring dialysis in most cases. Proteinuria and hematuria are present in about half the cases.
› Verified 9 days ago
| Entity Name | Patient First Maryland Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962423632 PECOS PAC ID: 4385538735 Enrollment ID: O20040209000543 |
News Archive
ULURU Inc. announced today that it has been issued U.S. Patent 7,910,135 – Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses.
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.
SARS-CoV-2-associated acute kidney injury is not uncommon. Many hospitalized COVID-19 patients - as many as 80% of critically ill COVID-19 patients, according to a current study - develop acute kidney injury, but without requiring dialysis in most cases. Proteinuria and hematuria are present in about half the cases.
› Verified 9 days ago
| Entity Name | Urgent Care Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174804918 PECOS PAC ID: 2163698101 Enrollment ID: O20111222000219 |
News Archive
ULURU Inc. announced today that it has been issued U.S. Patent 7,910,135 – Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses.
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.
SARS-CoV-2-associated acute kidney injury is not uncommon. Many hospitalized COVID-19 patients - as many as 80% of critically ill COVID-19 patients, according to a current study - develop acute kidney injury, but without requiring dialysis in most cases. Proteinuria and hematuria are present in about half the cases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David George Rorison, MD 5000 Cox Rd, Glen Allen, VA 23060-9263 Ph: (804) 822-4355 | David George Rorison, MD 8105 Ritchie Hwy, Pasadena, MD 21122-3905 Ph: (443) 573-0564 |
News Archive
ULURU Inc. announced today that it has been issued U.S. Patent 7,910,135 – Hydrogel Wound Dressing and Biomaterials Formed In Situ and Their Uses.
Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.
Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.
SARS-CoV-2-associated acute kidney injury is not uncommon. Many hospitalized COVID-19 patients - as many as 80% of critically ill COVID-19 patients, according to a current study - develop acute kidney injury, but without requiring dialysis in most cases. Proteinuria and hematuria are present in about half the cases.
› Verified 9 days ago
Dr. Gary M. Drake, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 8105 Ritchie Hwy, Pasadena, MD 21122 Phone: 443-573-0564 Fax: 443-573-0565 | |
Kevin Gerard Seaman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 8105 Ritchie Hwy, Pasadena, MD 21122 Phone: 443-573-0564 Fax: 443-573-0565 | |
Perry R Weisman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 33 Magothy Beach Rd Ste 102-103, Doctors Regional Medical Center, Pasadena, MD 21122 Phone: 410-255-7900 |